Parexel Helping Japan Address Drug Loss with “Ethnobridging” Studies, PI Still a Hurdle

Stanford Jhee, Corporate Vice President Scientific Affairs, Parexel International Japanese PI studies still pose a barrier for global companies to develop their medicines in Japan despite the recent regulatory reforms by local authorities, says a senior official of Parexel International...read more